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Bleeding changes the haemodynamics, compromising organ perfusion. In this study, the effects of bleeding followed by replacement
with hydroxyethyl starch 130/0.4 (HES) or lactated Ringer’s (LR) on cerebral oxygenation and electroencephalogram-derived
parameters were investigated. Twelve young pigs under propofol-remifentanil anaesthesia were bled 30mL/kg and, after a 20-
minute waiting period, volume replacement was performed with HES (GHES; 𝑁 = 6) or LR (GRL; 𝑁 = 6). Bleeding caused a
decrease of more than 50% in mean arterial pressure (𝑃 < 0.01) and a decrease in cerebral oximetry (𝑃 = 0.039), bispectral
index, and electroencephalogram total power (𝑃 = 0.04 and 𝑃 < 0.01, resp.), while propofol plasma concentrations increased
(𝑃 < 0.01). Both solutions restored the haemodynamics and cerebral oxygenation similarly and were accompanied by an increase
in electroencephalogram total power. No differences between groups were found. However, one hour after the end of the volume
replacement, the cardiac output (𝑃 = 0.03) and the cerebral oxygenation (𝑃 = 0.008) decreased in the GLR and were significantly
lower than in GHES (𝑃 = 0.02). Volume replacement with HES 130/0.4 was capable of maintaining the cardiac output and cerebral
oxygenation during a longer period than LR and caused a decrease in the propofol plasma concentrations.
1. Introduction
The choice of fluid administration in clinical situations where
it is urgent to restore macrohaemodynamic function should
also assure the best beneficial effects on microcirculation and
tissue oxygenation [1]. Rapid restitution of intravascular vol-
ume is essential to maintain the vital organs’ perfusion.There
are different intravascular volume replacement regimens for
providing haemodynamic stability after blood loss, including
blood and its components, synthetic colloids as dextrans,
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gelatines, and hydroxyethyl starch (HES), or crystalloids as
lactated Ringer’s solution (LR) [2, 3].
HES 130/0.4 is themost recent hydroxyethyl starch which
was created with a lower molecular weight and lower degree
of substitution to overcome the side effects of previous
heavier starches [4]. However, in June 2013 [5] the marketing
authorizations for all HES products for human patients
were suspended in the United Kingdom by the European
Medicines Agency. This decision was based on three large
randomized controlled trials [1, 6, 7] in which the use of HES
was associated with higher rates of acute kidney failure or
dialysis. Because HES is often used in veterinary patients,
there is a concern about the implications that the drug may
have in these patients. Thus, it is important to understand
the advantages and drawbacks of resuscitation with HES
compared to crystalloids.
Electroencephalogram-derived parameters such as the
bispectral index (BIS) have been suggested to reflect changes
in the cerebral perfusion during hemorrhagic shock followed
by resuscitation in pigs [8] and it would be interesting to
compare the effects of HES and crystalloids in this parameter.
However, recent data suggest that these BIS variations are
merely due to the anaesthetic depth until development of
lethal hypotension at which brain electrical activity cannot
be sustained [9, 10]. Near-infrared spectroscopy (NIRS) may
make it possible to study the regional cerebral blood flow
[11], while brain venous oxygenation (SvjO
2
)monitoringmay
yield useful information of general cerebral perfusion [12].
Acute bleeding and fluid replacement may also change
the pharmacokinetics of intravenous drugs [13, 14] such as
propofol, which is increasingly used in veterinary patients,
and it is important to understand its pharmacokinetics when
facing acute blood loss followed by volume replacement using
crystalloid or colloid solutions.
By understanding the posthaemorrhage effects of differ-
ent volume replacement solutions on brain oxygenation, elec-
troencephalogram, cardiovascular parameters, and propofol
pharmacokinetics, it is possible to improve brain and cardio-
vascular function and optimise the propofol titration.
This study addresses the effects of volume replacement
with a crystalloid (lactated Ringer’s) or a colloid (hydrox-
yethyl starch 130/0.4) solution on propofol plasma concentra-
tions, cerebral oxygenation, electroencephalogram-derived
parameters, and haemodynamics after severe acute bleeding
in pigs under propofol and remifentanil total intravenous
anaesthesia.
2. Material and Methods
All procedures were carried out under personal and project
licenses approved by the national regulatory office (Direcc¸a˜o
Geral de Veterina´ria—DGV000228).
Twelve healthy three-month-old large white pigs were
used in this study. The GLR pigs weighed 27.2 ± 3.1Kg and
the GHES weighted 26.8 ± 4.1Kg.
The pigs were fasted overnight but were permitted free
access to water. Blood samples were withdrawn from each
pig at the beginning and at the end of the study for hema-
tologic and biochemical analysis. All pigs were submitted to
general anaesthesia with propofol and remifentanil during
which the methodological procedures took place and were
submitted to the same monitoring and bleeding procedures.
These same animals were used for another study of the
effects of a remifentanil bolus on the electroencephalogram,
haemodynamics, and cerebral oxygenation which benefited
from the same monitoring setup and the same anaesthesia
but was performed before the start of the present study in the
same conditions for all animals and the effect of the bolus was
allowed to pass before the start of the present study.
These pigs were randomly assigned in two groups, which
differed only in the type of fluid used in the volume replace-
ment phase; six animals received hydroxyethyl starch 130/0.4
(GHES) (Voluven, Fresenius Kabi, Bad Homburg, Germany)
and six animals received lactated Ringer’s (GLR) (B Braun,
Melsungen, Germany).
2.1. Anaesthesia, Monitoring, and Equipment. All pigs were
premedicated with azaperone IM 4mg kg−1 (Stresnil, Janssen
Animal Health, Belgium) thirty minutes prior to the begin-
ning of anaesthesia induction. After premedication, a 22G
catheter was inserted in the right auricular vein for drug and
fluid administration. Two three-way stopcock valves were
used to connect the intravenous catheter to the maintenance
lactated Ringer’s (LR) delivery line and to the lines delivering
propofol 1% (Fresenius Kabi, Bad Homburg, Germany) and
remifentanil 20𝜇gmL−1 (Ultiva, GSK, Midlessex, UK). An
infusion pump (Braun, Melsungen, Germany) was used for
the administration of LR at a constant infusion rate of
6mL kg−1 h−1 + 1mL kg−1 h−1 for each kg above 20 kg of
weight [15] during the entire study period. Propofol and
remifentanil were delivered using two perfusion pumps
(Asena GH, Alaris Medical Systems, San Diego, CA) con-
trolled by the RugLoop II Waves software developed by
Tom De Smet (Demed Engineering, Temse, Belgium) and
Michel Struys (Ghent University, Gent, Belgium) running in
a personal computer.
Induction of anaesthesia was performed with a propofol
bolus of 4mg kg−1 while pigs were breathing 100% oxygen
via a facial mask. This was followed by tracheal intubation
with a 6.5mm endotracheal tube.The pigs weremechanically
ventilated with a mixture of 20% air + 80% oxygen, using
a Datex Carestation ventilator, with a tidal volume of 10mL
kg−1, respiratory rate of 12 to 14, and inspiration expiration
ratio of 1 : 3, with adjustments according to the observed
ETCO
2
in order to obtain a PaCO
2
of 40 ± 4mmHg.
After induction of anaesthesia, a propofol constant
infusion was started at a rate of 15mg kg−1 h−1 which
remained unchanged during the entire study period. Simul-
taneously, a remifentanil constant infusion was started at
a rate of 0.3 𝜇g kg−1min−1. After ending all monitoring
procedures, the remifentanil infusion rate was decreased to
0.2 𝜇g kg−1min−1 and was maintained unaltered during all
the study period. Peripheral oxygen saturation (SpO
2
) was
recorded by placing the probe on the pig’s tongue, and heart
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rate was collected by three ECG electrodes placed according
to Academy of Veterinary Cardiology Committee.
2.2. Haemodynamic Monitoring. After reaching stable anaes-
thesia (total muscle relaxation, absence of palpebral reflex,
and absence of haemodynamic response to interdigital space
clamping), the following invasive instrumentation proce-
dures were performed in each pig for placement of arterial
catheters in the left femoral artery (Leadercath, Vygon Cor-
poration, PA) for monitoring continuous blood pressure and
a 16 gauge catheter in the right femoral artery (Abbot Animal
Health, IL) for passive bleeding. A surgical approach to the
ventral cervical region was used in all pigs for introducing
two 7F Swan-Ganz optic catheters (Edwards, Life Sciences,
Irvine, CA): one in the internal jugular vein with its optic
tip in the sinus petrosus ventralis, for collecting data from
venous blood oxygen saturation (SvjO
2
), and the other in the
pulmonary artery, via left external jugular vein, for collecting
data from central venous pressure, pulmonary artery pressure
and cardiac output by the thermodilution method, and
pulmonary pressure.
A multiparametric haemodynamic monitor (Datex-
Ohmeda S/5, Helsinki, Finland) was used to collect all
haemodynamic and ventilatory data. The SvjO
2
was mea-
sured using an Oxymetrix 3 monitor (Abbott Laboratories,
North Chicago, IL, USA) also connected to the S/5 Datex
monitor. All data was recorded every five seconds in a per-
sonal computer, via a RS-232 interface, running the RugLoop
II Waves software.
2.3. Brain Monitoring. The fur on the skin over the fronto-
occipital region was shaved, and the skin grasped with fine
sandpaper and cleaned with acetone, and a BIS adhesive
electrode (Zipprep, Aspect Medical Systems, Natick, MA)
was placed in the left side of the head in the following
position: number 1 electrode was placed over the external
occipital protuberance; number 2 and number 4 electrodes
were placed over the left hemisphere; number 3 electrode was
placed over the rostral left portion of the frontal bone, at the
level of the left eye. The EEG was recorded at 256Hz using
a BIS XP monitor (Aspect Medical Systems, Natick, MA).
The monitor also recorded the bispectral index (BIS), elec-
tromyographic activity (EMG), signal quality index, spectral
edge frequency 95% (SEF) suppression ratio (SR), and total
power (TP). Data from the BIS monitor were recorded every
second in the personal computer running the RugLoop II
Waves software.
The near-infrared spectroscopy INVOS monitor 4100
with the software version 11.16.16 (Somanetics Corporation,
Troy, MI) was used continuously to monitor changes in
regional oxygen saturation (rSO
2
) in the left side of the head
using its noninvasive electrodes (SomaSensors, Somanetics
Corporation, Troy,MI).Data fromcerebral oxygen saturation
given by the INVOS was recorded continuously using ASYS
software [16] running in a second personal computer, with
the clock synchronizedwith that in the computer running the
RugLoop II Waves software.
An Oxymetrix 3 monitor (Abbott Laboratories, North
Chicago, LL, USA) with a 7F Swan-Ganz optic catheter
(Edwards, Life Sciences, Irvine, CA), with its optic tip placed
in the sinus petrosus ventralis, was used for collecting data
fromvenous blood oxygen saturation (SvjO
2
), formonitoring
the overall brain oxygenation.
2.4. Experimental Protocol. After completing all the neces-
sary instrumentation procedures, 30mL kg−1 of blood was
passively removed from each pig through the right femoral
artery, during approximately 20 minutes. Twenty minutes
after the bleeding has stopped, the volume replacement phase
started at 999mLh−1 with LR or HES 130/0.4 solution,
depending on the treatment group. The volume of HES
130/0.4 administered for volume replacement was 20mL kg−1
[17], and the volume of Ringer solution administered was
25% higher (25mL kg−1) than that used for HES based on
preliminary studies. These volumes were administered in the
external jugular vein, via the side port of the Swan-Ganz
catheter introducer (7F Intro-Flex, I500F7C, Edwards, Life
Sciences, Irvine, CA).
After the end of the volume replacement, all animals were
maintained under the same rates of propofol and remifentanil
for an additional one hour. At the end of the study, the pigs
were euthanized under general anaesthesia with intravenous
potassium chloride. At the end of the study all the pigs were
subjected to necropsy to check for correct positioning of the
catheters and direct visualization of the internal organs.
Cardiac output measurements using the thermodilution
method were performed just before the start of bleeding (𝑇
0
),
when 50% of the blood volume was removed, at the end of
the bleeding, at the end of the twenty-minute waiting period,
at the end of the volume replacement, and at the end of the
study.
Arterial blood samples were also collected for blood gas
analyses right before bleeding, at the end of the waiting
period, in the end of the volume replacement, and in
the end of the study using a Gem Premier 3000 analyser
(Instrumentation Laboratory, Massachusetts, USA).
During the study period, 3mL arterial blood samples
were collected from the right femoral artery into heparin con-
taining tubes for propofol and propofol metabolites quantifi-
cation in the plasma right before bleeding (𝐶
𝑝
0), 10 (𝐶
𝑝
1) and
15 (𝐶
𝑝
2)minutes after the beginning of bleeding, at the end of
bleeding (𝐶
𝑝
3), tenminutes after the beginning of the waiting
period (𝐶
𝑝
4) and at the end of the waiting period (𝐶
𝑝
5), and
15 (𝐶
𝑝
6), 30, 45, and 60minutes after the beginning of volume
replacement (𝐶
𝑝
7, 𝐶
𝑝
8, and 𝐶
𝑝
9). After blood collection the
plasma was separated through centrifugation at 3000 rpm for
15 minutes and was immediately placed at −77∘C and stored
until analysis.
Propofol plasma concentrations as well as its free
metabolites (2,6-diisopropyl-1,4-quinol and 2,6-diisopropyl-
1,4-quinone) [18] were determined by gas chromatography
mass spectrometry according to Guitton and colleagues [19]
with some adjustments, as described in Silva and colleagues
[20]. For the calibration curve, the nonconjugated metabo-
lites were chemically synthesized since these compounds are
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not commercially available. The purified metabolites (>95%)
were subsequently used as GC-MS standards.
The plasma concentrations of propofol were divided by
the total volume of propofol administered to check for
influences of the duration of propofol infusion on the final
concentrations of the drug.
2.5. Electroencephalographic Analysis. The BIS monitor
recorded the raw EEG at 256Hz which was further converted
to be processed offline using the MATLAB software
(MathWorks, Natick, MA). The signal’s sampling frequency
was first decreased 2 times, resulting in 128Hz. The indices
approximate entropy (AE) and permutation entropy (PE)
were derived from EEG epochs of 8 seconds after filtering
using a butterworth bandpass filter of 8th order with cutoff
frequencies of 0.5 and 30Hz followed by removal of the
mean value of the signal in order to get out any threshold. AE
and PE were computed according to published algorithms
[21–23]. Briefly, the calculation of the AE depends on three
factors: the embedding dimension (𝑚), the number of
samples considered for each calculation (𝑁), and the noise
threshold (𝑟). In this study 𝑁 = 1024, 𝑚 = 2, and 𝑟 = 0.2
were selected for AE calculation, based on previous studies
[24]. For the PE calculation, the length of subvectors (𝑚) and
the analyzed signal interval (length 𝑁) are main factors. In
this study, we used 𝑚 = 3 and 𝑁 = 1024. A more detailed
description of the AE and PE calculation can be found in
published works [22, 23, 25].
The spectral parameters were corrected for the presence
of burst suppression patterns, using the values of SR (sup-
pression ratio) recorded by the BIS monitor, according to
the correction factor proposed by Rampil [26]. The same
correction factor was applied to PE resulting in BSPE,
calculated as follows: BSPE = PE × (1 − SR/100) [20, 27].
The raw EEGwas recorded along with the BIS, EMG, SEF,
andTP, all derived automatically from the BISmonitor.These
parameters were included in the overall analysis of the indices
of anaesthetic depth.
2.6. Statistics. Four different study periods were analysed: (1)
the bleeding period; (2) the 20-minute waiting period; (3)
the volume reposition period; and (4) the final period until
euthanasia. Each period was normalized in 10 different 10%
parts. Each 10% part represented the average of 30 seconds of
consecutive measurements.
The percentage of oxygen extraction (SpO
2
-SvO
2
) was
also analyzed.
Data were tested for normal distribution and homogene-
ity of variance using the Shapiro-Wilk normality test and
Levene test, respectively. Haemodynamic, cerebral oxygena-
tion, propofol and metabolites plasma concentrations, and
electroencephalographic data were compared within groups
and between groups using two-way repeated measures anal-
ysis of variance, with Bonferroni corrections for pairwise
comparisons which was performed separately for each study
period.
Correlation analysis was performed between the stud-
ied parameters using the Pearson and Spearman Rank
correlation coefficients for normal and non-Gaussian data,
respectively. Correlation analysis was performed during the
bleeding period and during the volume replacement period.
Statistical analysis was performed using Graphpad prism
(Version 5, GraphPad Software Inc., SanDiego, CA). Data are
expressed asmean ± SD;𝑃 < 0.05was considered statistically
significant.
3. Results
The bleeding period had a mean duration of 19.8 ± 0.8 (GLR)
and 20.3 ± 2.6 (GHES), the waiting period lasted for 24.9 ± 2.7
(GLR) and 24 ± 3.2 (GHES) minutes, the volume replacement
period lasted for 43.8 ± 5.7 (GLR) and 33.1 ± 4.8 (GHES)
minutes, and the period between the end of replacement
and the end of study was 53.5 ± 16.1 (GLR) and 54.1 ± 14.9
(GHES) minutes. The average blood volume withdrawn was
680 ± 78mL in the GLR and 671 ± 104mL in the GHES.
The blood temperature of the pigs was maintained
between 39 and 40∘C (normothermia for pig) during the
whole anaesthesia. The changes in arterial blood gases were
comparable between the two groups throughout the whole
study (Table 1). There were no significant changes in the
oxygen extraction (SpO
2
-SvjO
2
) between the two groups,
although there were variations throughout time (𝑃 = 0.03)
(Table 2).
Bleeding Period. Propofol plasma concentration (𝐶
𝑝
)
increased during bleeding (𝑃 < 0.01), and propofol
free metabolites (𝐶met) also changed throughout time
(𝑃 < 0.001), increasing until 15 minutes after the beginning
of bleeding and decreasing from 15 minutes to the end of
bleeding (Table 2 and Figure 1).
Regarding the EEG-derived parameters, during bleeding,
BIS (𝑃 = 0.04) and TP (𝑃 < 0.001) decreased significantly.
No significant changes were found in the other studied EEG-
derived parameters or in any parameter between the two
groups (Table 3).
SvjO
2
and cerebral oxygen saturation reflected by INVOS
decreased throughout bleeding (𝑃 = 0.039), but no differ-
ences were found between the two groups (𝑃 > 0.1) as shown
in Table 2 and Figure 2.
During the bleeding period there was a significant
decrease in blood pressure (𝑃 < 0.001) and no significant dif-
ferences were found between groups. In GLR, MAP decreased
by 54.6% from the beginning to the end of bleeding and
in GHES it decreased by 52.3% in 𝑇10 when compared to
baseline (𝑇
0
) (Table 2 and Figure 3).There were no significant
changes inHR throughout time (𝑃 = 0.98) or between groups
(𝑃 = 0.52) (Table 2). CO decreased throughout bleeding
(𝑃 < 0.001) similarly in both groups (𝑃 = 0.47) and DPAP
(𝑃 < 0.05) decreased in both groups as shown in Table 2 and
Figure 3.
3.1. Correlation Analysis. During bleeding there were signif-
icant correlations between MAP and CO (𝑟 = 0.70; 𝑃 <
0.001), HR and 𝐶
𝑝
(𝑟 = −0.59; 𝑃 < 0.001), CO and cerebral
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Table 1: Results from arterial blood gas analysis performed before the beginning of bleeding (1), at the end of the waiting period (2), in the
end of the volume replacement (3), and in the end of the study one hour after the end of the volume replacement (4).
Before bleeding End of waiting End of volume replacement End of study
GLR GHES GLR GHES GLR GHES GLR GHES
PH 7.45 ± 0.06 7.44 ± 0.03 7.4 ± 0.08 7.4 ± 0.08 7.5 ± 0.07∗ 7.5 ± 0.05∗ 7.5 ± 0.06 7.46 ± 0.04
PCO2 (mmHg) 46.2 ± 5.8 47.5 ± 4.1 48.5 ± 6.9 48.9 ± 9.1 44.3 ± 6.4
∗ 43.0 ± 3.9∗ 44.8 ± 5.6 45.9 ± 3.5
PO2 (mmHg) 217.4 ± 73.9 188 ± 48.8 230.5 ± 62.0 195.5 ± 38.0 233.5 ± 49.9 221.0 ± 65.0 225.0 ± 40.9 201.8 ± 50.6
NA+ (mEq/L) 134.1 ± 5.1 136 ± 2.0 133.5 ± 4.8 137.4 ± 2.2 133.7 ± 5.0 137.1 ± 1.3 134.2 ± 5.0 137.9 ± 1.64
K+ (mEq/L) 5.8 ± 1.7 5.1 ± 1.2 5.3 ± 1.0 4.6 ± 0.73 5.13 ± 1.0 4.0 ± 0.5 4.9 ± 1.2 4.40 ± 0.52
CA++ (mg/dL) 1.1 ± 0.22 1.2 ± 0.2 1.1 ± 0.1 1.1 ± 0.10 1.1 ± 0.04 0.98 ± 0.21 1.2 ± 0.3 1.18 ± 0.22
GLUC (mg/dL) 60.9 ± 22.6 57.9 ± 13.5 63.3 ± 22.6 80.2 ± 25.7∗∗ 60.3 ± 28.2 81.5 ± 15.9 68.6 ± 27.8 68.3 ± 13.3
LACT (mmol/L) 2.1 ± 1.1 2.0 ± 1.0 2.8 ± 1.0∗ 2.2 ± 0.68∗ 2.9 ± 0.7£ 1.7 ± 0.5£ 1.8 ± 1.0∗∗£ 1.11 ± 0.34∗∗£
HEMATOC (%) 26.1 ± 4.6 26.4 ± 5.6 17.1 ± 2.5∗∗ 20.9 ± 4.2∗∗ 15.9 ± 1.13 14.5 ± 2.1 18.2 ± 4.2 17.5 ± 3.5
HCO3
− (mEq/L) 31.6 ± 2.5 32.4 ± 2.0 31.0 ± 1.6∗∗ 30.9 ± 0.9∗∗ 30.5 ± 1.4 30.0 ± 2.73 31.6 ± 1.1∗ 32.6 ± 1.39∗
PT (g/dL) 4.3 ± 0.8 4.1 ± 0.25 — — — — 3.2 ± 0.6# 2.78 ± 0.19#
GLR: group that received lactated Ringer’s for volume replacement; GHES: group that received hydroxyethyl starch for volume replacement. Mean ± standard
deviation is shown. Significantly different from the previous measurement: ∗𝑃 < 0.05, ∗∗𝑃 < 0.01 level. £Significant differences between groups at the 𝑃 <
0.05 level. #Significant differences between the measurement “before bleeding” and the measurement “end of study.”
oxygen saturation (𝑟 = 0.54; 𝑃 < 0.001), and CO and 𝐶
𝑝
(𝑟 = −0.55; 𝑃 < 0.05).
Regarding the EEG-derived parameters, SR and TP cor-
related negatively with each other (𝑟 = −0.58; 𝑃 < 0.001)
and AE correlated with PE (𝑟 = 0.69; 𝑃 < 0.001) and SRPE
(𝑟 = 0.78; 𝑃 < 0.001).
Waiting Period. At the end of the waiting period a significant
increase from the values previous to bleeding was observed
in plasma lactate levels from 2.1 ± 1.1 to 2.8 ± 1.0 in GLR (𝑃 <
0.01) and from 2.0 ± 1.0 to 2.2 ± 0.68 in GHES (𝑃 < 0.01).
No changes were found in𝐶
𝑝
and𝐶met between or within
groups (Table 2 and Figure 1).
Regarding the EEG-derived parameters, TP decreased
during the waiting period (𝑃 < 0.001) and PE increased
(𝑃 = 0.01), as shown in Table 3.
SvjO
2
decreased (𝑃 < 0.05) and cerebral oxygen satura-
tion showed no significant differences (𝑃 = 0.43) (Table 2 and
Figure 2). There was a significant decrease in the hematocrit
from 26.1 ± 4.6% to 17.1 ± 2.5% in GLR (𝑃 < 0.01) and from
26.4 ± 5.6% to 20.9 ± 4.2% in GHES (𝑃 < 0.01). There were no
significant differences between groups in these parameters.
MAP increased (𝑃 < 0.001) similarly in both groups. CO and
HR showed no significant changes throughout time (𝑃 > 0.1)
as shown in Table 2.
No significant differences between groups were found in
this period in any parameter.
Volume Replacement Period. 𝐶
𝑝
did not change significantly
in this period (Table 2 and Figure 1).
TheTPof the EEG increased significantly (𝑃 < 0.001) and
PE decreased significantly during replacement (𝑃 = 0.01) as
shown in Table 3.
MAP (𝑃 < 0.001), HR and CO (𝑃 < 0.05), DPAP
(𝑃 < 0.01), SvjO
2,
and cerebral oxygen saturation (𝑃 < 0.01)
increased significantly in both groups (Table 2 and Figure 2).
No significant differences between groups were found in
this period in any parameter.
3.2. Correlation Analysis. During volume replacement, cor-
relations were found between MAP and 𝐶
𝑝
(𝑟 = −0.66;
𝑃 < 0.01), HR and CO (𝑟 = 0.81; 𝑃 < 0.001), and HR and
𝐶
𝑝
(𝑟 = −0.52; 𝑃 = 0.02).
Regarding the EEG-derived parameters, therewere corre-
lations between TP andHR (𝑟 = 0.62;𝑃 < 0.001) and a strong
correlation between TP and SR (𝑟 = −0.70; 𝑃 < 0.001). BIS
showed correlation with SRSEF (𝑟 = 0.58𝑃 < 0.001). TP was
correlatedwith𝐶
𝑝
(−0.68;𝑃 < 0.001). AEwas correlatedwith
PE (𝑟 = 0.60;𝑃 < 0.001) andwith SRPE (𝑟 = 0.76;𝑃 < 0.001).
Final Phase. At the end of the study, the 𝐶
𝑝
was significantly
higher in the GLR than the GHES (𝑃 = 0.02), but the propofol
metabolites concentration was not different between groups
(𝑃 = 0.06). When the 𝐶
𝑝
values were divided by the total
volume of propofol administered to check for influences of
the duration of propofol infusion on the final concentrations
of the drug, the values were still significantly lower in GHES
(𝑃 = 0.033; GLR with 0.07±0.02 versus GLR with 0.05±0.01).
There were no significant differences in the total volume of
propofol administered between groups (𝑃 = 1.0).
No significant differences between groups were found in
this period in any of the remaining parameters.
MAP decreased significantly in the final hour (𝑃 = 0.02),
HR showed no changes (𝑃 = 0.07), and CO decreased only
in the GLR (𝑃 = 0.03) but was kept constant on the GHES
(𝑃 = 0.77) (Table 2 and Figure 3). Similarly, SvjO
2
decreased
significantly in GLR (𝑃 = 0.008) but was unaltered in GHES
(𝑃 = 0.64) (Table 2 and Figure 2). There were significant
differences in DPAP between groups (𝑃 = 0.04).
Regarding the EEG-derived parameters, no changes were
observed in any of the parameters in the final period
(Table 3).
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All of the pigs survived the study period. Postmortem
evaluation during necropsy revealed correct positioning of all
catheters and no macroscopic damage in the internal organs.
4. Discussion
This study had two major objectives: (1) to investigate the
effects of acute bleeding on propofol plasma concentra-
tions, cerebral oxygenation, EEG-derived parameters, and
haemodynamics and (2) to compare the effects of volume
replacement with a colloid (hydroxyethyl starch 130/0.4)
and a crystalloid (lactated Ringer’s) on the same parameters
in pigs under propofol and remifentanil total intravenous
anaesthesia.
The amount of blood withdrawn from each pig in
our study represents around 50% of the pig’s total blood
volume [28], causing a severe haemodynamic depression
and a decrease in the cerebral oxygenation, accompanied
by an increase in the propofol plasma concentrations and
electroencephalographic depression, reflected in a decrease
in TP and BIS.
At the end of the volume replacement with HES or with
LR, the plasma concentrations of propofol were higher in the
LR group, when compared to the HES group, although no
significant differences were observed in the EEG parameters
between the two groups.
The increased propofol concentrations observed in our
study after bleeding are in agreement with reports from
previous studies that also observed an increase in plasma
concentrations of propofol after hemorrhagic shock [5, 13,
15]. However, our study reveals different effects caused by
volume replacement with crystalloid or colloid solutions on
the pharmacokinetics of propofol. In a study in pigs fluid
resuscitation was found to restore the pharmacokinetic alter-
ation of propofol after hemorrhagic shock, but not the phar-
macodynamic alteration [15]. The mechanism is unclear, but
some reports suggest that it could be explained by an increase
in the unbound propofol after aggressive haemodilution [29].
In another study in pigs the effect of three kinds of fluid
infusion after high-volume blood loss on the pseudo-steady-
state propofol concentration was compared: a volume of LR
or hydroxyethyl starch equivalent to the blood withdrawn
and a threefold volume of LR. The results showed that the
pseudo-steady-state concentration is influenced differently
depending on themethod of fluid infusion after haemorrhage
[30]. In the present study, differences in the circulatory blood
volume between the two groups could explain the different
concentrations of propofol obtained. However, it could also
be explained by a possible interaction between HES and
propofol, as found in previous laboratorial work [31, 32].
According to distinct characteristics of the physiologic
solutions, colloids may assure better tissue perfusion when
compared to crystalloids [33]. During the volume replace-
ment phase, HES 130/0.4 could have assured a more efficient
hepatic, renal, and pulmonary perfusion by increasing tissue
microcirculation, which may have occurred less efficiently
in the LR group [34]. However, because there were no
significant differences in cardiac output between the two
groups during replacement, the existence of overall supply
differences between the two groups cannot be inferred.
Near-infrared spectroscopy (NIRS) such as the INVOS
monitor used in this study may be used to noninvasively and
continuously monitor changes in the regional oxygen satura-
tion, reflecting the balance between cerebral oxygen supply
and demand [11, 35]. In normal physiological conditions,
changes in cerebral blood flow result in changes in oxygen
delivery to the peripheral cortex, which could be detected by
NIRS. On the other hand, the brain venous blood oxygen
saturation (SvjO
2
) monitoring provides information about
the global brain oxygenation but does not provide informa-
tion about regional cortex blood supply [36]. Cerebral oxygen
saturation recordedwith the INVOSmonitor has been shown
to have an excellent correlation with the invasive methods
of assessing cerebral oxygenation in a study in humans [11].
The decrease in cerebral oxygen saturation values reflected by
INVOS during bleeding in our study followed the decrease in
cardiac output and preload.
In our study, both cerebral oxygen saturation reflected
by INVOS and SvjO
2
decreased during bleeding reflecting
changes in cerebral perfusion and oxygenation caused by
hypovolemia. In healthy individuals, the brain blood supply is
under regulation of the brain itself, if the mean arterial pres-
sure is kept between 60 and 160mmHg [37]. Mean arterial
pressure values below 60mmHg, such as those observed in
our study, may cause a reduction in cerebral blood flow [38].
Furthermore, diastolic pulmonary pressure values which
reflect the preload decreased during bleeding whichmay also
explain the possible decrease in brain perfusion.
It is known that hypovolemia increases the effect of
propofol in the brain [13, 39] which has been explained
mainly by an increase in drug concentration induced by a
reduction in the distribution volume and clearance and by
an increase in end-organ sensitivity. Recent reports suggest
that increases in the unbound propofol during shock could
explain this mechanism [29].This could have been the origin
of the EEG changes observed during bleeding in the present
study. On the other side, some studies also show the potential
of the EEG to reflect ischemia during surgery [40–43]. The
burst suppression seems to reflect cerebral ischemia due to
the decrease in the amplitude of the EEG normally associated
with cerebral ischemia.However, because in the present study
bleeding also caused an increase in the propofol plasma
concentrations, it is difficult to tell if the increase observed
in SR and TP was due to hypotension or a relative increase in
the propofol concentrations.
Despite the significant decrease in MAP caused by bleed-
ing, no compensatory increase in heart rate was observed.
This might be related to the marked resetting effect of propo-
fol on the reflex set point previously observed in humans [44].
During the 20-minute waiting period after bleeding, animals
revealed a physiologic capacity to minimize the haemody-
namic depression. The endogenous homeostatic vasopressor
mechanisms, including the sympathetic nervous system, the
renin-angiotensin-aldosterone system, and local determi-
nants of vascular tone, including nitric oxide and endothelin,
are responsible for the initial compensatory mechanisms
for hypovolemia. Once the compensatory reserve of these
10 Veterinary Medicine International
homeostaticmechanisms is exceeded, cardiovascular decom-
pensation and shock may occur [45].
During the 20-minute waiting period, there were no
changes in the propofol plasma concentrations, and the
decrease in SvjO
2
and in the electroencephalographic depres-
sion reflected by TP wasmore evident. Although in our study
it was not possible to observe significant changes in any of the
other EEG-derived parameters, this observation supports the
hypothesis that EEG-derived parameters may reflect changes
in brain hypoperfusion [40, 46, 47].
Fluid replacement caused a recovery in the haemody-
namic variables and in cerebral oxygenation both in the
group that received LR and in the group that received the
HES. There were also changes in the EEG parameters with
an increase in the TP, but with no differences between the
two groups during the volume replacement phase. How-
ever, approximately one hour after the end of the volume
replacement and when comparing with the end of volume
replacement values, the group that received LR showed a
decrease in cardiac output values and lower SvjO
2
values and
in cerebral oxygen saturation reflected by INVOS. This did
not occur with the group that received HES that showed
similar CO and SvjO
2
values when compared to the end of
volume replacement. This difference might be related to a
better preload maintenance with HES as can be observed in
the diastolic pulmonary pressure values.
The SvjO
2
is an invasive technique to measure cerebral
oxygenation using the internal jugular venous blood oxygen
saturation. However, its use is not straightforward and dif-
ficulties in its use may be related to potential malposition
of catheter, resulting in contamination with extracerebral
blood, as well as motion artefacts, whichmay render readings
obtained by SvjO
2
unreliable [12, 48].
Furthermore, it has been shown that in pigs the cerebral
outflow is not only via the internal jugular vein [49]. This
may explain the almost absent response of SvjO
2
to bleeding
in one of the groups in our study. In our study, the reversal
of the haemodynamic depressing effects of bleeding was
similar in both volume replacement regimens, which is
in agreement with the observations of a recent study in
human patients with septic shock [50]. Nevertheless, the
maintenance of a higher CO and cerebral oxygen saturation
reflected by INVOS reveals a better capacity of HES to
maintain the intravascular volume and cerebral perfusion
after replacement, with a longer lasting effect than LR.
These results are in agreement with previous suggestions
that colloids improve cardiac performance in patients with
hypovolemia [51, 52] and are probably related to the fact
that crystalloids are electrolyte solutions that lack intrinsic
colloid osmotic pressure, entering the interstitial space [53]
and remaining in less of 30%of the total volume administered
in the intravascular space [51, 54]. On the other hand, colloids
have an osmotic pressure similar to plasma, staying largely
confined to the intravascular space; this allows an increase
in mean arterial pressure with greater longevity in cases of
severe hypovolemia [55].
Some limitations of this study should be noted. The
BIS as a monitor of anaesthetic depth in animals has not
been validated. Although several studies showed that BIS
decreased with increasing anaesthetic doses [56–58]; the
index was developed from a database of electroencephalo-
grams recorded in humans and caution is required when
interpreting its values in animals. Another important point is
the variation in the duration of study periods, as they might
have introduced variability in the results.
Also, because an isobaric hemorrhage model was not
adopted in this study, different metabolic states could be
observed in the studied groups after bleeding which could
compromise the comparisons performed. However, both
groups of animals underwent similar changes in mean
arterial pressure values during bleeding and also similar
blood parameters values indicating similar metabolic state.
Another limitation may be related to the fluid infusion
schemes adopted. The fluid infusion was chosen based on
preliminary trials in which a similar haemodynamic recovery
(considering MAP values) was observed. However, after
analysis of the data in the present paper, namely, the cardiac
output and pulmonary artery diastolic pressure, it is possible
to conclude that, although the recovery during replacement
was similar in both groups, the preload seemed to be better
maintained by HES when the fluids were no longer being
administered.
5. Conclusions
In conclusion, after around 50% of the total blood, the
intravenous delivery of HES 130/0.4 was associated with
a decrease in propofol plasma concentrations indicating a
possible effect of HES in the propofol pharmacokinetics.
Volume replacement with lactated Ringer’s and HES 130/0.4
had similar restoration of all the physiologic parameters,
but HES 130/0.4 was capable of maintaining the cardiac
output and cerebral oxygenation until one hour after the end
of its administration, while lactated Ringer’s was not. The
INVOS monitor seems promising for cerebral oxygenation
monitoring in veterinary anaesthesia.
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